GlaxoSmithKline Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (378)

Latest Posts

About This Stock More About This Stock
These Are Some Of The Coronavirus Vaccine Candidates
Article By: ValueWalk
Monday, May 25, 2020 6:28 PM EDT
As far as which coronavirus vaccine candidates will be tested first, researchers will look at production capacity and the amount of immune response generated in early trials and animal studies.
In this article: GSK, PFE, SNY, MRNA, ALT, JNJ, SVA, NVAX, INO, AZN
Profit From The Genomics Market Momentum With These ETFs
Article By: Zacks Investment Research
Saturday, May 23, 2020 7:04 PM EDT
It appears that growing demand for personalized medicine, solid investments and higher R&D activities can make genomics the next big thing in the investing space. We highlight a host of ETFs that investors can keep tabs on.
In this article: GSK, GNOM, PBE, ARKG, IDNA
E Daily Stock Pick: GlaxoSmithKline
Article By: Fredrik Arnold
Thursday, May 14, 2020 5:56 AM EDT
Glaxo's price per share closed at $42.90 yesterday. A year ago their price was $39.21.
In this article: GSK
Glaxo (GSK) Beats Earnings & Revenue Estimates In Q1
Article By: Zacks Investment Research
Wednesday, April 29, 2020 9:45 AM EDT
Glaxo reported core earnings of 93 cents per American depositary share in the first quarter of 2020, which beat our consensus estimate of 79 cents.
In this article: GSK
E Staying Long Against High-Frequency Traders
Article By: James Gornick
Wednesday, April 22, 2020 11:10 AM EDT
Time to send the message for the Institutional Investors to run back into ownership--long positions, and bring the bullish goring of the short-selling bears on $INO to break their trading funds within their banks.
In this article: GSK, SNY, INO Also: REGN, MRNA


Latest Tweets for $GSK

No tweets yet!